The field of research in 5-hydroxytryptamine has increased dramatically over the past decade, with far reaching implications in psychiatry. The CINP (the international neuropharmacological organization) chose this topic for its first President's Workshop and the record of this meeting is presented here. The contributors are active researchers with a distinguished track record.